Oncovue to Be Commercially Released in Uk by Okc-Based Intergenetics

Summary

---

InterGenetics will release OncoVue in the United Kingdom and Ireland under an exclusive agreement with Opaldia, a genetic health service provider with a network of clinics. The test helps determine a woman's risk of developing sporadic breast cancer.

"OncoVue has undergone over seven years of research, and the genetic information for this test came from the testing of over 8,000 women with and without breast cancer from five geographic regions of the United States, giving us the support to introduce the test to an international market." said Craig Shimasaki, CEO and president of Oklahoma City-based InterGenetics.

See the full content of this document

Extract

---

Oncovue to Be Commercially Released in Uk by Okc-Based Intergenetics

For the OncoVue test, women first answer a simple medical history questionnaire, then sw...

See the full content of this document

---